Milton Keynes, U.K., March 4, 2026 – As we step into the first days of spring with warmer weather – prime time to spend more time in the garden, at café catch ups, and on holiday – research released for National Pet Vaccination Month (March) reveals alarming gaps in awareness that are putting thousands of […]
Milton Keynes, 26th March 2026 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Veterinary Medicines Directorate (VMD) has approved NUMELVI ® (atinvicitinib) Tablets for Dogs. NUMELVI is the first and only second‑generation Janus kinase (JAK) inhibitor indicated from six months of age (and 3kg) […]
MILTON KEYNES, U.K., 20 January 2026 – A University of Stirling student who is the latest recipient of the Nikos Steiropoulos Aquaculture Scholarship from MSD Animal Health UK says the award has helped to “open a door she could only have dreamed of”. The scholarship, sponsored by MSD Animal Health UK, a division of Merck […]
MILTON KEYNES, U.K., 5th June 2025 – In an independent survey carried out by Kingshay in association with British Dairying magazine, MSD Animal Health’s SenseHub herd monitoring system has been announced as the UK’s best cow wearable monitoring technology. The poll of British dairy farmers saw SenseHub competing against 16 other herd monitoring systems to […]
Milton Keynes, UK, – 30th April 2025 – MSD Animal Health UK Ltd, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Veterinary Medicines Directorate has granted the marketing authorisation for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets both external and internal parasites. The monthly, […]
Milton Keynes,U.K., March 27, 2024 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK). A study commissioned by MyPet.com, founded by global animal health provider MSD Animal Health, surveyed 2,000 UK cat and dog owners and discovered 81 percent think of their pet as one of the loves of […]
MILTON KEYNES, U.K., 19th March 2025 – MSD Animal Health UK Limited (a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has launched a farmer and veterinary focused initiative to showcase how the proactive use of herd monitoring and identification technologies can improve animal health, welfare and productivity. In the first phase […]
Parasiticide Treatment for Dogs Offers Only Year-Round Flea and Tick Protection Milton Keynes, U.K., 11th March, 2025 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has received the S&P Global Animal Health 2024 Best New Companion Animal Product award for the injectable formulation of BRAVECTO® (fluralaner). It is […]
MILTON KEYNES, U.K., 27 November 2024 – The University of Stirling has announced Laila Al Farsi as the inaugural recipient of the Nikos Steiropoulos Aquaculture Bursary. This prestigious award, sponsored by MSD Animal Health UK, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), supports students with a passion for aquaculture and allows […]
MILTON KEYNES, U.K., 21st November 2024 – MSD Animal Health UK, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is delighted to announce the winner and runners up of the MSD Animal Health UK’s Research Bursary Awards Day presentations. Each year, MSD Animal Health UK offers bursaries aimed at veterinary students, veterinary […]